UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 120, 2025

UNIVERSAL SAFETY PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

Maryland	001-31747	52-0898545
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)

11407 Cronhill Drive, Suite A, Owings Mills, Maryland 21117

(Address of principal executive offices) (Zip Code)

(410) 363-3000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol (s)		Name of each exchange on which registered
Common Stock, $0.01 par value		UUU		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 15.~~01            Entry~~07 ~~into~~Submission of Matters to a ~~Material~~Vote ~~Definitive~~of ~~Agreement~~Security Holders.

~~The~~On October 20, ~~information~~2025, ~~set~~Universal ~~forth~~Safety ~~under~~Products, Inc., ~~Item~~a 5Maryland corporation (the “Company”) held a special meeting of stockholders (the “Special Meeting”).02 ~~below~~As of September 17, 2025, the record date for the Special Meeting, isthe ~~incorporated~~Company inhad ~~its~~outstanding ~~entirety~~and ~~herein~~entitled byto ~~reference~~vote 2,312,887 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), which constitutes all of the outstanding voting capital stock of the Company.

~~Item 5~~At the Special Meeting, the stockholders voted on four proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.02S.           ~~Departure~~ Securities and Exchange Commission on September 17, 2025. At the Special Meeting, stockholders approved proposals 5 6, 7 and 8, each of ~~Directors~~which orwere ~~Certain~~presented ~~Officers;~~for ~~Election~~a vote. The tables below set forth the number of ~~Directors;~~votes ~~Appointment~~cast for and ofagainst ~~Certain~~or ~~Officers;~~withheld, ~~Compensatory~~and ~~Arrangements~~the number of ~~Certain~~abstentions ~~Officers~~or broker non-votes, for each matter voted upon by the Company’s stockholders.

~~On October 1, 2025, Universal Safety Products, Inc.,~~Proposal aFive: ~~Maryland~~The ~~corporation~~approval ~~(the~~of ~~“Company”) entered into an employment agreement (~~the ~~“Agreement”) with Harvey B. Grossblatt, the~~ Company’s ~~President~~2025 ~~and~~Equity ~~Chief~~Incentive ~~Executive Officer, to continue to serve as the Company’s President and Chief Executive Officer through July 31, 2027~~Plan.

Pursuant to the Agreement, Mr. Grossblatt will be paid a base salary of $352,286 per annum (the “Base Salary”). Additionally, Mr. Grossblatt is entitled to bonus compensation based upon milestone amounts of the Company’s receipt of gross proceeds from capital raises from the date of the Agreement through July 31, 2027, with the first bonus equal to $2.5 million upon receipt of gross proceeds of at least $100 million, with additional bonuses of $1.0 million for each $100 million of gross proceeds between $200 million and $900 million, with a final potential bonus of $500,000 upon gross proceeds of $1 billion, which would result in total bonus payments to Mr. Grossblatt of $10 million. Mr. Grossblatt is also entitled to life, health and disability insurance benefits, medical reimbursement, automobile allowance, and Company paid retirement plan contributions.

For				Against				Abstain				Broker Non-Votes
	931,883				58,273				2,839				504,550

~~If the Agreement is terminated by Mr. Grossblatt~~Proposal ~~for~~Six: ~~good~~The ~~reason,~~approval ~~Mr. Grossblatt is entitled to receive his compensation through any balance~~ of ~~the~~equity ~~employment~~issuances ~~term plus a lump sum payment equal~~ to ~~his last 12 months Base Salary, health benefits for three years, and an additional lump sum payment payable on each of~~ the ~~first three anniversaries of the termination equal to the 401(k) plan contribution the~~ Company’s ~~would~~directors ~~have~~and ~~made~~executive ~~on behalf of the Company had he remained employed by the Company~~officers.

If Mr. Grossblatt’s employment is terminated following or in anticipation of a “change of control” of the Company, Mr. Grossblatt will be entitled to receive a lump sum payment equal to his base salary for the balance of the Agreement’s term plus three times Mr. Grossblatt’s last 12 months Base Salary. In addition, Mr. Grossblatt is entitled to receive health benefits for three years, and an additional lump sum payment payable on the anniversary of the termination equal to the 401(k) plan contribution the Company would have made on behalf of the Company had he remained employed by the Company for three years. In the event of a change in control Mr. Grossblatt will receive an amount equal to three times his Base Salary for the last 12 months, limited to 2.99 times Mr. Grossblatt’s average annual taxable compensation from the Company which is included in his gross income for the five taxable years of the Company ending before the date on which the change of control occurs.

For				Against				Abstain				Broker Non-Votes
	861,029				107,310				24,656				504,550

~~If the Agreement is terminated by the Company~~Proposal ~~due~~Seven: toThe ~~Mr. Grossblatt’s death~~approval, ~~Mr. Grossblatt’s estate is entitled to receive a lump sum payment equal to his base salary~~ for ~~the~~purposes ~~greater~~ of ~~the~~complying ~~balance~~with Rule 713(a) of the ~~Agreement’s~~NYSE ~~term or one year~~American, ~~reduced by any individual life insurance benefits~~ the ~~premiums~~ ~~for~~issuance ~~which are paid for~~ by the Company~~, plus the amount~~ of ~~the~~additional ~~Company’s~~shares ~~last 401(k) plan contribution made on behalf~~ of ~~Mr. Grossblatt.~~Common InStock ~~addition,~~underlying ~~Mr. Grossblatt~~the Company’s ~~estate~~convertible isnote ~~entitled~~issued pursuant to the ~~health~~securities ~~insurance~~purchase ~~and medical reimbursement~~agreement ~~benefits~~dated ~~for the longer of the balance of the term or three years following the date of death~~August 13, ~~or the cash equivalent thereof~~2025.

If the Agreement is terminated by the Company due to Mr. Grossblatt’s disability, Mr. Grossblatt is entitled to the continuation of the payment of his base salary for the balance of the term, reduced by any group or individual disability income insurance benefits the premiums for which are paid for by the Company and Social Security disability benefits paid to Mr. Grossblatt. In addition, Mr. Grossblatt is entitled to the health insurance and medical reimbursement benefits and a payment equal to the 401(k) plan contribution the Company would have made on behalf of the Company had he remained employed by the Company, for the longer of the balance of the term or three years following the date of disability, or the cash equivalent thereof.

For				Against				Abstain				Broker Non-Votes
	953,153				32,616				7,226				504,550

Proposal Eight: The ~~Agreement~~approval ~~generally~~of ~~prohibits~~the ~~Mr. Grossblatt~~adjournment of the Special Meeting to a later date or time, if necessary, to permit further ~~from~~solicitation ~~competing~~and ~~with~~vote of proxies if, based upon the ~~Company~~tabulated ~~during~~vote at the ~~term~~time ~~and~~of ~~during~~the ~~any~~Special ~~subsequent~~Meeting, ~~period~~there ~~during~~are ~~which~~not hesufficient ~~receives~~votes to ~~compensation~~approve ~~from~~other proposals before the ~~Company~~Special Meeting.

The Employment Agreement includes a “clawback” provision in which Mr. Grossblatt agrees that the Company can recoup any compensation or benefits provided to him that are required by applicable law to be subject to recovery or recoupment.

For				Against				Abstain				Broker Non-Votes
	1,294,006				194,077				9,462				0

~~The~~Based ~~foregoing~~on ~~description~~the proxies and ballots received prior to the opening of the ~~Agreement~~Special ~~does~~Meeting, there were not ~~purport~~sufficient votes to beapprove ~~complete~~the ~~and~~Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class B Common Proposal or the Voting Rights Proposal (as each is ~~qualified~~defined and described in ~~its~~the ~~entirety~~Proxy byStatement). Accordingly, ~~reference~~the Chairman of the Special Meeting only called for a vote on the above listed proposals, with the last proposal considered a vote on proposal 8, to authorize the ~~Agreement~~adjournment ~~filed~~of asthe ~~Exhibit~~Special Meeting to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class ~~10.1~~B ~~hereto~~Common Proposal and isthe ~~incorporated~~Voting ~~herein~~Rights ~~by reference~~Proposal.

2The Chairman then adjourned the Special Meeting without opening the polls on the Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class B Common Proposal or the Voting Rights Proposal, which were scheduled to be submitted to a vote of the Company’s stockholders at the Special Meeting, to allow additional time for voting (the “Adjourned Special Meeting”).

The Adjourned Special Meeting will reconvene at 12:00 p.m. Eastern Time on Friday, November 14, 2025. The Company’s stockholders of record as of the close of business on the original record date for the Special Meeting, September 17, 2025, can attend the reconvened Adjourned Special Meeting by visiting meetnow.global/MKMHAK9. Stockholders who have previously submitted their proxy or otherwise voted and who do not wish to change their vote do not need to take any action. During the period of adjournment, the Company will continue to accept stockholder votes on the Authorized Share Increase Proposal, the Blank Check Preferred Proposal, the Class B Common Proposal and the Voting Rights Proposal.

This Current Report may be deemed to be solicitation material in respect of the solicitation of proxies from stockholders for the Special Meeting. Before making any voting decision, the Company strongly encourages all of its shareholders to read the Proxy Statement (including any amendments or supplements thereto) and other proxy materials relating to the Special Meeting, including this Current Report, which are available free of charge on the SEC’s website at www.sec.gov.

The Securities and Exchange Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and which involve risks, uncertainties and reflect the Registrant’s judgment as of the date of this Current Report on Form 8-K. Forward-looking statements may relate to, among other things, operating results and are indicated by words or phrases such as “expects,” “should,” “will,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.

Where You Can Find Additional Information

Investors and security holders will be able to obtain documents filed with the Securities and Exchange Commission free of charge at the Commission’s website, www.sec.gov. Security holders may also read and copy any reports, statements and other information filed by the Company with the Commission, at the SEC public reference room at 100 F Street, N.E., Washington D.C. 20549. Please call the Commission at 1-800-SEC-0330 or visit the Commission’s website for further information on its public reference room.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits:

Exhibit No.		Description
10.1*		Employment Agreement, dated October 1, 2025, by and between Universal Safety Products, Inc. and Harvey B. Grossblatt.
101		Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
104		Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).

* Indicates management contract or compensatory plan or arrangement.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	UNIVERSAL SAFETY PRODUCTS, INC.
Dated: October 2, 2025	/s/ Harvey B. Grossblatt
Dated: October 20, 2025	/s/ Harvey B. Grossblatt
	Harvey B. Grossblatt
	President and Chief Executive Officer

Filing Compare · UNIVERSAL SAFETY PRODUCTS, INC.